Cargando…

The Association of EBV and HHV-6 Viral Load with Different NK and CD8(+) T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis

OBJECTIVE: Epstein-Barr virus (EBV) and Human Herpes virus 6 (HHV-6) are believed to involve in multiple sclerosis (MS) pathogenesis. Natural killer (NK) and CD8(+) T cells have essential roles in handling viral infections and their phenotypic and functional properties may be influenced following ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salehi, Zahra, Beheshti, Masoumeh, Nomanpour, Bizhan, Khosravani, Pardis, Naseri, Maryam, Sahraian, Mohammad Ali, Izad, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royan Institute 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665980/ https://www.ncbi.nlm.nih.gov/pubmed/34939755 http://dx.doi.org/10.22074/cellj.2021.7308

Ejemplares similares

Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns
por: Salehi, Zahra, et al.
Publicado: (2016)

Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2020)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2018)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
por: Gilmore, Wendy, et al.
Publicado: (2020)

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
por: Lundy, Steven K., et al.
Publicado: (2016)

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders
por: Sanchez, Sandra, et al.
Publicado: (2020)

DNA Sensors’ Signaling in NK Cells During HHV-6A, HHV-6B and HHV-7 Infection
por: Bortolotti, Daria, et al.
Publicado: (2020)

Differential regulation of CD4(+) T cell subsets by Silymarin in vitro and in ovalbumin immunized mice
por: Namdari, Haideh, et al.
Publicado: (2018)

Exploring the effect of vitamin D(3) supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis
por: Rolf, Linda, et al.
Publicado: (2017)

Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I
por: Mohebi, Nafiseh, et al.
Publicado: (2015)

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
por: Yavari, Fatemeh, et al.
Publicado: (2021)

The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis
por: Tavassolifar, Mohammad javad, et al.
Publicado: (2020)

EBV, HCMV, HHV6, and HHV7 Screening in Bone Marrow Samples from Children with Acute Lymphoblastic Leukemia
por: Morales-Sánchez, A., et al.
Publicado: (2014)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
por: Bülbül, Göksenil, et al.
Publicado: (2022)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
por: Khatibi, Ali, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases
por: Baharlooi, Hussein, et al.
Publicado: (2019)

HPV Infection, but Not EBV or HHV-8 Infection, Is Associated with Salivary Gland Tumours
por: Hühns, Maja, et al.
Publicado: (2015)

Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy
por: Handous, Imene, et al.
Publicado: (2020)

A CD8(+) NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
por: McKinney, Eoin F., et al.
Publicado: (2021)

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
por: Rezaee, Mehdi, et al.
Publicado: (2022)

Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
por: Adjei, Andrew A, et al.
Publicado: (2008)

EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda
por: Tumwine, Lynnette K, et al.
Publicado: (2010)

Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients
por: Rasmussen, NS, et al.
Publicado: (2015)

HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
por: Bacha, Dhouha, et al.
Publicado: (2017)

Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV
por: Liu, Chih-Yi, et al.
Publicado: (2022)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
por: Foshati, Sahar, et al.
Publicado: (2023)

Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients
por: Atamna, Alaa, et al.
Publicado: (2023)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

Balance Changes in Patients With Relapsing-Remitting Multiple Sclerosis: A Pilot Study Comparing the Dynamics of the Relapse and Remitting Phases
por: Findling, Oliver, et al.
Publicado: (2018)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Abnormal multisensory integration in relapsing–remitting multiple sclerosis
por: Giurgola, Serena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7qku15odt20sa43esvkqjhvrbk